Saraf & Partners Advised Fortis Healthcare On Acquisition Of Shrimann Superspeciality Hospital

Saraf & Partners Advised Fortis Healthcare On Acquisition Of Shrimann Superspeciality Hospital
Saraf and Partners advises Fortis Healthcare on its acquisition of Shrimann Superspeciality Hospital, Jalandhar. Fortis Hospotel Limited, a wholly-owned subsidiary of Fortis Healthcare Limited, has entered into definitive agreements for the acquisition of Shrimann Superspecialty Hospital, Jalandhar from Shriman Enterprises (a partnership firm) by way of a slump sale, for an overall purchase consideration of approximately INR 462 crores.
Saraf & Partners Acts For Fortis In Acquisition Of 31.52% Stake In Its Subsidiary Agilus

Saraf & Partners Acts For Fortis In Acquisition Of 31.52% Stake In Its Subsidiary Agilus
Saraf and Partners acted for Fortis Healthcare Limited in relation to the acquisition of 31.52% equity stake in its subsidiary, Agilus Diagnostics Limited, from three private equity investors, namely – NYLIM Jacob Ballas India Fund III LLC, Resurgence PE Investments Limited and IFC – International Finance Corporation for a cash consideration of approx. INR 1770 crores (approx. USD 207 million).
The transaction team was led by Senior Partner Vaibhav Kakkar, Partner Sahil Arora and Partner Debarpan Ghosh.
Source: Saraf & Partners’ LinkedIn Page